Patents by Inventor Tory H. Powner

Tory H. Powner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha-substitution of unprotected &bgr;-amino ester compounds
    Patent number: 6433209
    Abstract: Methods for stereoselective substitution in which a (mono or un)-&agr;-substituted unprotected &bgr;-amino ester compound or salt thereof is reacted with an aliphatic electrophile in the presence of a base selected from alkyl lithium compounds, lithium hydride, lithium amide, lithium dialkyl amides and alkali hexamethyldisilylamines.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: August 13, 2002
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Sithamalli V. Chandramouli, Michael K. O'Brien, Tory H. Powner
  • Process for preparing N6-substituted adenosine derivatives
    Patent number: 6429315
    Abstract: This invention is directed to a process for preparing N6-substituted adenosine derivatives, to intermediates useful therefor and to methods of preparing these intermediates.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: August 6, 2002
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Adam W. Sledeski, Luc Grondard, Matthew R. Powers, Tory H. Powner, Michael K. O'Brien, Ching T. Tsuei, Patrick Leon, Gregory G. Kubiak, Laurence Pailleres-Hubert, Benoit Viguier
  • Preparation of [1S-[1A,2B,3B,4A(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl propyl]amino] -3H-imidazo[4,5-B]pyridin-3-yl]-N-ethyl-2,3-dihydroxycyclopentanecarboxa mide
    Patent number: 6143894
    Abstract: This invention is directed to methods for the preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-chloro-2-thienyl) methyl]propyl]amino]-3H-imidazo[4,5-b]pyridin-3-yl]-N-ethyl-2,3-dihydroxyc yclopentanecarboxamide, methods for the preparation of intermediates thereto, and to said intermediates themselves.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: November 7, 2000
    Assignee: Aventis Pharmaceuticals Products Inc.
    Inventors: Michael K. O'Brien, Herve Garcia, Patrick Leon, Tory H. Powner, Laurence W. Reilly, Harshavadan C. Shah, Michael D. Thompson, Ching T. Tsuei, Benoit J. Vanasse, Francis L. Walther